Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Surveillance topic
No spam. Unsubscribe anytime.
Senate bills seek automated overdose mapping and naloxone reporting to fill data gaps; privacy concerns raised
Summary
Two bills would automate EMS data sharing with an overdose mapping tool and add naloxone dispensation data to the state prescription monitoring program; supporters say better data will target response and save lives, while privacy advocates warned of mission creep and unintended consequences
Two related bills addressing opioid surveillance and naloxone distribution data were presented to the Senate Health and Human Services Committee.
Senate File 2499 would permit de-identified EMS data to be shared automatically with the Overdose Detection Mapping Application Program (ODMAP), a tool used by nearly 300 Minnesota jurisdictions. Supporters said automation would reduce manual entry, speed alerts about local overdose spikes and allow more timely responses. Senator Mohamud (sponsor) noted the bill does not mandate reporting and that only essential, non-identifying information (location, time, suspected substances, naloxone use) would be shared with authorized users. Jeremy Drucker, director of the Office of Addiction and Recovery, and Dylan Ferguson from the Office of EMS testified in favor and described the bills as ways to improve targeted public-health responses as federal funding becomes constrained.
Senate File 2806 would require dispensers to report distribution of opioid over-dose reversal agents (naloxone) to the state’s Prescription Monitoring Program (PMP). The bill allows retention of de-identified naloxone dispense data to improve trend analysis and would restrict access to authorized users for public-health purposes. Supporters said the change fills a data gap on where naloxone is being distributed in the community and would enable better planning and resource allocation.
Civil-liberty and privacy groups testified in opposition to the naloxone reporting bill. Matt Flanders of Citizens’ Council for Health Freedom opposed expanding the PMP and warned of “mission creep,” arguing that adding naloxone and other non-controlled “reportable substances” to the PMP could chill people from obtaining life-saving medication. He also opposed longer PMP data retention and urged the committee to scrutinize access controls and long-term retention policies.
Committee members asked whether the PMP change would expose individuals inappropriately and whether maintenance and contractor personnel could gain access to sensitive records. Supporters said the naloxone data would be used in aggregate, internal analysis and that the bills included restrictions on access. Senators asked for additional safeguards; several members said the bills warranted further review in judiciary or another policy forum to examine privacy and data-sharing safeguards.
Both bills were laid over for further consideration. Senate File 2499 was recommended to the Judiciary Committee; Senate File 2806 was held over for possible inclusion pending further work.
